Fay Cafferty

Principal Statistician at the Institute of Cancer Research Clinical Trials and Statistics Unit (ICR-CTSU)

[Science and Innovation at Cancer Research UK @CRUKresearch]

[3/3]

Robert Huddart, Fay Cafferty and Alison Reid received a Clinical Trial Award to assess circulating serum microRNA as a #biomarker for relapse in Phase 2/3 trial to reduce the burden of standard active surveillance in stage I germ cell tumours.

#CRUKFunded #tyacancer

@robert_huddart | @FayCafferty

[Follow us on Bluesky @ICR-CTSU @ICR_CTSU]

We have an exciting new opportunity for a Principal Statistician to join our team working on cancer #ClinicalTrials. You can find more details about the role, including how to apply, at the link below. #Stats https://t.co/h614CkhBxU

[Follow us on Bluesky @ICR-CTSU @ICR_CTSU]

We're looking for people with #Cancer which has spread to their spine, or their relatives, to join our discussion group on 20th July to help us design our new #ClinicalTrial, SENSE. If you would like to be involved, you can sign up here: https://t.co/1SsC6jQxf7 #PPI

[VJ Oncology @VJOncology]

🎥 @robert_huddart of @ICR_London discusses TRISST: the cost-effectiveness of alternative imaging and surveillance schedules for testicular seminoma

Watch: 👉https://t.co/QNmMu88VBZ👈

@ASCO #GU23 #PCSM #BlcSM #kcsm #TSCsm #UroOnc

[Fay Cafferty @FayCafferty]

@MRCCTU @ASCO @CHEyork @robert_huddart

[UCL Innovative Clinical Trials Unit @innovativectu]

New findings from the TRISST trial support #MRI as a cost-effective option to replace potentially harmful CT scans for monitoring early stage #TesticularCancer.

These results were presented on Saturday at
@ASCO #GU23. Learn more👉 https://t.co/9vUpeqz0up

[Prof Hakim Dehbi @HakDehbi]

First webinar of the year this Friday about the online MSc Statistics for Clinical Trials @ucl starting in Sept 2023.

Join the call if you're interested in studying statistics in clinical trials :-) Share if you know someone who might be.

https://t.co/jsYXeuufPJ

@ICTM_UCL

[Christina Yap @ChristinaBYap]

Interested in #clinicaltrials and innovative trial designs?

Exciting opportunity for an undergraduate student to join the Early Phase and Adaptive Trials Team @ICR_CTSU for a paid summer vacation scholarship!

[Follow us on Bluesky @ICR-CTSU @ICR_CTSU]

Interested in working in #Cancer #ClinicalTrials? We are currently looking for a Clinical Trials Programme Manager to join our team. For more details visit:
https://t.co/HyaL4Qqtye

[Fay Cafferty @FayCafferty]

Please get in touch if you want to find out more about this project 👇🏻

[Follow us on Bluesky @ICR-CTSU @ICR_CTSU]

And another working with Dr @FayCafferty and Professor @ChristinaBYap on developing guidance and exemplars for a multi-stakeholder approach to estimands in cancer clinical trials:

https://t.co/ZcZb9Ux64D

[Follow us on Bluesky @ICR-CTSU @ICR_CTSU]

We have 3 PhD opportunities available via the MRC #TrialsMethodology research partnership.

[MRC-NIHR Trials Methodology Research Partnership @MRCNIHRTMRP]

We are delighted to announce that the full list of projects for our @The_MRC 2023 TMRP Doctoral Training Partnership PhD studentships is now available and open to applications. Deadline: 16 Jan 2023 https://t.co/uEI5fAPoqi

[Fay Cafferty @FayCafferty]

New PhD opportunity in cancer clinical trial methodology - work with patients, clinicians and other stakeholders to ensure we ask the right questions (and design trials that provide the answers) using estimands. @ChristinaBYap @ICR_CTSU @MRCNIHRTMRP https://t.co/DaShgxuikC

[Follow us on Bluesky @ICR-CTSU @ICR_CTSU]

There's still time to apply for our Clinical Trials Programme Manager or Bioinformatician/Translational Statistician roles.
You can find out more details and apply here:
https://t.co/ggDXF0AIxd

[Alison Tree 💙 @alison_tree]

My first Tweetorial 🧵 2 year toxicity results of PACE B published here. Big thanks to the 🇬🇧🇨🇦 and🇮🇪collaborators and the 874 men with prostate cancer who made this trial possible https://t.co/mERz2ox8TM

[Follow us on Bluesky @ICR-CTSU @ICR_CTSU]

We're currently looking for a Clinical Trials Programme Manager to join our team. For more information about the role and how to apply, please see here: https://t.co/NW6vi5CmFc
#ICRJobs #ResearchJobs

[Follow us on Bluesky @ICR-CTSU @ICR_CTSU]

Our Parable #ClinicalTrial enrolled its first patient yesterday. Parable aims to investigate the effects of #ProtonBeamTherapy compared to #Radiotherapy in #BreastCancer patients with an increased risk of side effects affecting the heart.

[Follow us on Bluesky @ICR-CTSU @ICR_CTSU]

Read the new plasmaMATCH paper, highlighting the challenges of implementing a platform trial using liquid biopsies to match participants to targeted treatments for #BreastCancer: https://t.co/T9QB6UOaXM

[Robert Huddart💙 @robert_huddart]

Fewer scans, less imaging radiation- equivalent results What’s not to like?
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST) @MRCCTU @FayCafferty https://t.co/qkT2cGPF01

[UCL Innovative Clinical Trials Unit @innovativectu]

Are MRI #scans as effective as CT scans in detecting testicular #cancer relapse? How often should men have scans post-surgery?

The TRISST #Trial found that relapses can be detected at an early-stage with less scans & using MRI

@FayCafferty @CRUKresearch
https://t.co/owFub7jcS7